Syngene International management believes that the Bio-secure act will help US companies balance their supply chain in the long run over the next 5-10 years rather than just for a few weeks. They see positive signs such as healthy lead indicators and numerous pilot projects being undertaken. They expect improved topline from the second half of FY25 as they have already witnessed a 50% rise in enquiries since Q1FY25.

#syngene #pharma #pharmaceutical